Strahlman currently works at Altria Group, Inc., as Independent Director from 2020, Losonoco Ltd., as Director from 2009, and Eyenovia, Inc., as Independent Director from 2022. Dr. Strahlman also ...

Storm clouds hung low above a community center in Jackson, where pastor Andre Devine invited people inside for lunch. Hoagies ...

This pharma giant was expected to deliver for investors after its split with Haleon, but the GSK share price has underperformed the market. The post What’s going on with the GSK share price now?

University at Buffalo researchers shed some light on an enduring neuroscience mystery: How exactly does a mutated huntingtin protein (HTT) cause Huntington's disease?

GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 ...

The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates ...

Q1 2025 Earnings Call Transcript April 30, 2025 GSK plc beats earnings expectations. Reported EPS is $1.13, expectations were ...

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as ...

European stocks closed higher on Wednesday, as investors pored through another slew of earnings and reacted to ...

The Elton John AIDS Foundation is delighted to announce the appointment of three new members to its Board of Directors - ...

You can reach Andrew on Signal at drewqjoseph.45. GSK’s blood cancer drug Blenrep won regulatory approval in the U.K. on Thursday, marking the medicine’s return to the market after it was ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in its marketing and prescription ...